The original Aphira buyout offer was nothing more than a ruse orchestrated by insiders/note holders to dump shares. It was a joke, a really bad one.
Even so, GGB is not going after ACB, the rumor is ACB is buying out the CBD segment of GGB. I suspect this is being done for two reasons:
1. ACB needs exposure to US CBD assets and has no problem diluting current shareholders.
2. GGB note holders has forced GGB's hand in selling off that segment in order for them to get some of their money back. The deal will likely be for $300-$400M in an all share transaction. This will allow the note holders to exchange a portion of their shares of GGB for those of ACB, which is much more liquid than GGB. It's going to be near impossible to get GGB back to $2.00USD, which is where the notes conversion price sits. It would be easy for them to dump ACB shares at that price, not so much GGB.
Of course I'm speculating, but I don't see any other way out for insiders/note holders without something like the above-described scenario. The mall kiosk idea just isn't all that appealing.
News 
Market Data 
Discover 
AI
